Ray Dalio Viatris Inc Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Viatris Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 610,869 shares of VTRS stock, worth $5.37 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

610,869

Previous 2,293,878 73.37%

Holding current value

$5.37 Million

Previous $28.6 Million 81.37%

% of portfolio

0.03%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$8.68 - $12.42 $14.6 Million - $20.9 Million	-1,683,009 Reduced 73.37%	610,869 $5.32 Million
Q4 2024 Feb 13, 2025	BUY	$11.32 - $13.37 $10.8 Million - $12.8 Million	955,786 Added 71.43%	2,293,878 $28.6 Million
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $9.9 Million - $11.6 Million	959,473 Added 253.41%	1,338,092 $15.5 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $1.45 Million - $1.73 Million	-143,842 Reduced 27.53%	378,619 $4.02 Million
Q1 2024 May 14, 2024	BUY	$11.27 - $13.53 $4.13 Million - $4.96 Million	366,474 Added 234.94%	522,461 $6.24 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $531,155 - $657,130	-60,565 Reduced 27.97%	155,987 $1.69 Million
Q3 2023 Nov 13, 2023	SELL	$9.59 - $11.35 $1.14 Million - $1.34 Million	-118,407 Reduced 35.35%	216,552 $2.14 Million
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $1 Million - $1.14 Million	-111,234 Reduced 24.93%	334,959 $3.34 Million
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $1.13 Million - $1.51 Million	-122,901 Reduced 21.6%	446,193 $4.29 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $684,197 - $907,032	78,463 Added 15.99%	569,094 $6.33 Million
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $1.7 Million - $2.23 Million	-200,578 Reduced 29.02%	490,631 $4.18 Million
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $2.7 Million - $3.33 Million	271,140 Added 64.55%	691,209 $7.24 Million
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $1.64 Million - $2.58 Million	167,264 Added 66.16%	420,069 $4.57 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $71,246 - $86,509	5,893 Added 2.39%	252,805 $3.42 Million
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $660,221 - $753,897	-49,828 Reduced 16.79%	246,912 $3.35 Million
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $3.31 Million - $4.12 Million	255,408 Added 617.94%	296,740 $4.24 Million
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $561,701 - $766,295	41,332 New	41,332 $577,000

Others Institutions Holding VTRS

# of Institutions

1,136

Shares Held

953M

Call Options Held

4.15M

Put Options Held

2.65M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account